The Role of miRNA in the Regulation of Angiogenesis in Ischemic Heart Disease

Curr Probl Cardiol. 2023 Jun;48(6):101637. doi: 10.1016/j.cpcardiol.2023.101637. Epub 2023 Feb 10.

Abstract

Despite continued improvements in primary prevention and treatment, ischemic heart disease (IHD) is the most common cause of mortality in both developing and developed countries. Promoting angiogenesis and reconstructing vascular network in ischemic myocardium are critical process of postischemic tissue repair. Effective strategies to promote survival and avoid apoptosis of endothelial cells in the ischemic myocardium can help to achieve long-term cardiac angiogenesis. Therefore, it is of great importance to investigate the molecular pathophysiology of angiogenesis in-depth and to find the key targets that promote angiogenesis. Recently years, many studies have found that microRNAs play important regulatory roles in almost all process of angiogenesis, including vascular sprouting, proliferation, survival and migration of vascular endothelial cells, recruitment of vascular progenitor cells, and control of angiopoietin expression. This review presents detailed information about the regulatory role of miRNAs in the angiogenesis of IHD in recent years, and provides new therapeutic ideas for the treatment of IHD.

Publication types

  • Review

MeSH terms

  • Cardiovascular Physiological Phenomena
  • Endothelial Cells / metabolism
  • Humans
  • MicroRNAs* / genetics
  • Myocardial Ischemia* / genetics
  • Myocardial Ischemia* / metabolism

Substances

  • MicroRNAs